Platelet adhesion and aggregation undoubtedly play a central role in haemostasis, but the nature of the change in the platelet membrane when it becomes 'sticky' is not established. This communication describes a new way of influencing platelet aggregation which may give a clue to the nature of this change.
Only one other report, in 1909, claims that mucopolysaccharide stains have a physiological effect: brilliant cresyl blue inhibited clot retraction (Achard and Aynard, 1909) which is now known to depend on normal platelet function, and the addition of high concentrations of cresyl blue have been reported to influence platelet aggregation (Muir and Mustard, 1967) . Mucopolysaccharides have been reported in the surface coat of the platelets (Behnke, 1968; Nakao and Angrist, 1968; French, Adams, and Sheppard, 1970) and so they may be involved in surface phenomena (Shirasawa and Chandler, 1969; White, 1970) . One of the most important of these phenomena is the development of stickiness. Mucopolysaccharide stains used in light or electron microscopy (Luft, 1966; Tice and Barrnett, 1965; Scott and Willett, 1966) have been shown to precipitate anionic mucopolysaccharides in vitro (Walton and Ricketts, 1954 Thus their effect on platelet aggregation was tested since aggregability must reflect the membrane change here referred to as the development of 'stickiness'.
Methods and Materials
Fresh human citrated (0-32 %) platelet-rich plasma was prepared and 2 ml aliquots were stirred in the aggregometer cuvette (O'Brien, Heywood, and Heady, 1966) with the addition, after two minutes at 37°C, of 0-1 ml of saline buffered with barbitone to pH 7-3 alone (the control) or saline containing sufficient stain to give the final concentrations quoted; if the added stain did not cause aggregation, then 0-1 ml of an aggregating agent was added. The light transmission of the platelet-rich plasma was continuously monitored and a tracing was obtained that recorded the degree of aggregation-a deflection down-or disaggregation against time. When strongly coloured stains were added the electrical system had to be adjusted and so an equivalent filter was introduced into the light path of the controls. All 1 Alcian blue, 05 to 0005 mg/ml, when added to platelet-rich plasma did not itself cause aggregation, but if ADP or another aggregating agent (thrombin, adrenaline, or collagen) was then added the expected response was markedly increased (Fig. 1) . On occasion this potentiating effect was demonstrable even at alcian blue 0 5 ,ug/ml or 0-38 ,uM.
2 Alcian blue, 0-2 to 0-6 mg/ml, added to platelet-rich plasma, itselfcausedadose-dependent wave of aggregation after an initial delay (Fig. 2) .
3 Higher concentrations of alcian blue caused less aggregation ( Fig. 3 ) until finally at about 4 mg/ml no aggregation occurred and then the addition of strong ADP or other aggregation agent had no effect. was selected and adenosine 5 mM added before the alcian blue, then aggregation was inhibited; aggregation by stronger alcian blue was hardly affected by adenosine at this strength. The aggregation tracings obtained with alcian blue suggest a release reaction. Accordingly 0-2 ml aliquots were taken one minute after the addition of 0 5 mg/ml alcian blue either to platelet-rich or to platelet-poor plasma. The aliquots from plateletrich plasma added to substrate platelet-rich plasma caused aggregation; the aliquots from platelet-poor plasma did not. Thus an aggregating agent had been released. Preincubation of plateletrich plasma with aspirin 5 mM or from a donor taken hours after he had eaten aspirin did not prevent subsequent alcian blue-induced aggregation. Alcian blue added to platelet-poor plasma had no effect. Alcian green added to platelet-rich plasma gave results similar to those with alcian blue.
LANTHANUM SALTS
The addition of lanthanum nitrate, 7-5 mg/ml, to platelet-rich plasma profoundly decreased aggregation induced by strong ADP, and at all attainable lanthanum concentrations inhibition was shown to be competitive. By adding ADP alone in increasing amounts a family of aggregation curves is obtained. Increasing concentrations of lanthanum from 0-1 mg/ml to 2-0 mg/ml added before strong ADP caused increasing inhibition and gave an exactly similar family of curves (Fig. 4) . This type of competitive inhibition was demonstrable over a wide range of ADP concentrations (05 ,uM to 0-5 mM), and with lanthanum from 7 mg/ml to 0-1 mg/ml (Fig. 5) Normally aggregation induced by all the usual aggregating agents mentioned above was completely inhibited by 5 mg/ml of ruthenium red or of the trichloride. Lower concentrations of ruthenium (0.5 to 005 mg/ml) gave results with the four aggregating agents which were exactly parallel to those using lanthanum, and inhibition was again shown to be competitive (Fig. 6 ).
TOLUIDINE BLUE AND BRILLIANT CRESYL

BLUE
At concentrations of 0-1 mg/ml and 0-2 mg/ml respectively these dyes inhibited all aggregation, and at lower concentrations aggregation was Lanthanum nitrate was added to platelet-rich plasma to achieve the following final concentrations: A 7 5 mg/ml; B 6-2 mg/ml; C S mg/ml; D 2 5 mg/ml; E saline only (the control). Two minutes later A DP 5 ,uM was added. Human red cells were obtained from citrated blood and washed three times in barbitonebuffered saline. These were then suspended in buffered saline at a concentration of 100,000/cmm in the platelet aggregometer. The addition of three stains at varying and critical concentrations caused immediate aggregation which usually proceeded linearly (Table and Fig . 7 ). The addition of plasma or serum prevented aggregation.
EFFECT OF THESE STAINS ON HEPARIN
Substrate platelet-poor plasma, 01 ml, and 0-2 ml saline were clotted by adding 0 I ml thrombin (10 U/mI) which gave a clotting time of about 10 seconds. Heparin 0-1 ml (0-4 U/ml) was then added in place of 01 ml of saline and this gave a clotting time of 35 seconds. The addition of stains in place of the last 0 1 ml of saline caused a return of the clotting time to 10 to 15 seconds. The order of addition was plasma, stain, heparin, and thrombin (Table) . Accordingly it is concluded that these stains can neutralize heparin. (Seaman and Vassar, 1966) when it becomes sticky. At the same time platelet factor 4 (heparin-neutralizing activity) develops on the membrane (O'Brien, Finch, and Clark, 1970) and this must carry a positive charge. The cationic stains are attracted to heparin and to acidic mucopolysaccharides (Scott and Willett, 1966) . Presumably a reduction of the plateletnegative charge could cause aggregation, but with more stain a reversal of charge could lead to inhibition of aggregation. However this may be, the present findings support the inference from electron microscopy that platelet mucopolysaccharide is involved in platelet stickiness (Behnke, 1968; Nakao and Angrist, 1968; Shirasawa and Chandler, 1969; French, Adams, and Sheppard, 1970; White, 1970) .
